Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-0.39	5.74	5.77
Graham Fair Price	41.42	3.73	2.64
PEG	-86.96	0.01	-0.11
Price/Book	13.00	0.37	0.32
Price/Cash Flow	-35.33	2.94	4.55
Prices/Earnings	-43.50	1.41	2.50
Price/Sales	-43.50	0.51	0.91
Price/FCF	-35.33	2.94	4.55
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	0.00	0.26	0.26
Operating Margin	0.00	0.12	0.12
ROA	100.00	0.03	0.02
ROE	0.03	0.06	100.00
ROIC	0.03	0.05	101.98
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.03	-0.15	-81.96
Dividends QOQ	0.00	< 0.005	100.00
EBIT QOQ	-0.09	1.00	1005.58
EPS QOQ	-0.23	1.00	333.33
FCF QOQ	0.05	0.75	1356.01
Revenue QOQ	-0.40	1.00	150.98
Naive Interpretation	member

03 - Financial Growth · Best

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	107.34	53.67	-50.00
Days Sales Outstanding (DSO)	57.88	32.10	-44.54
Inventory Turnover	0.84	1.68	100.00
Debt/Capitalization	0.33	0.33	-2.07
Quick Ratio	0.79	0.87	10.11
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	3.09	3.09	< 0.005
Cash	0.89	0.98	9.48
Capex	-0.08	-0.15	-100.00
Free Cash Flow	0.22	0.38	74.74
Revenue	1.10	2.21	100.00
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.37	1.37	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	2.28	2.01	-11.66
Naive Interpretation	Member

06 - Financial Health · Weak

Rating